FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W4323308811> ?p ?o ?g. }

• W4323308811 endingPage "596" @default.
• W4323308811 startingPage "592" @default.
• W4323308811 abstract "COVID-19 is an emerging disease that attacks the respiratory and systemic systems. Various treatments have been used for COVID-19, but no antiviral agents seemed to be efficacious. Many medicinal plants are commonly used for viral infections in Indonesia, including the guajava leaf. The study aimed to determine the effects of Psidium guajava extract supplementation on inflammation markers of asymptomatic and mild COVID-19 patients. The conversion time of PCR results was also evaluated. This study was an experimental, single-blinded, randomized clinical trial (ClinicalTrials.gov: NCT04810728) comparing the efficacy of P. guajava extract at the dose of 1000 mg/8h on top of standard treatment with the standard treatment only for asymptomatic and mild COVID-19 subjects. The primary endpoints were neutrophil and lymphocyte percentages as well as the neutrophil/lymphocyte ratio (NLR) on day 7 of the treatment. The secondary endpoints were high-sensitivity c-reactive protein (hs-CRP) level, PCR-based conversion time, and recovery rate at weeks 2 and 4. A total of 90 subjects were enrolled, and there were 40 subjects in the P. guajava (experimental) group and 41 subjects in the control group who completed the research. On day 7, significantly lower percentage of neutrophil (52.4% vs 58.9%, p = 0.002), higher lymphocyte percentage (35.5%, vs 29.7%, p = 0.002), and lower NLR (1.5 vs 2.1, p = 0.001) were demonstrated in the experimental versus control group. The PCR-based conversion time was shorter (14 days vs 16 days, p < 0.001), and recovery rate at 2 and 4 weeks were higher (49% vs 27%, p = 0.03 and 100% vs 82%, p = 0.003, respectively) in the experimental group. There were no differences in the baseline characteristics. P. guajava extract supplementation reduced neutrophil and increased lymphocyte percentages which led to reduced NLR, accelerated PCR-based conversion time, and increased recovery rate in subjects with mild and asymptomatic COVID-19 infection." @default.
• W4323308811 created "2023-03-07" @default.
• W4323308811 creator A5007560495 @default.
• W4323308811 creator A5041368940 @default.
• W4323308811 creator A5075901927 @default.
• W4323308811 creator A5084802647 @default.
• W4323308811 date "2023-04-01" @default.
• W4323308811 modified "2023-10-12" @default.
• W4323308811 title "The effect of Psidium guajava Leaves’ extract for mild and asymptomatic corona virus Disease-19" @default.
• W4323308811 cites W1981904991 @default.
• W4323308811 cites W2032376562 @default.
• W4323308811 cites W2047697332 @default.
• W4323308811 cites W2091857624 @default.
• W4323308811 cites W2118970688 @default.
• W4323308811 cites W2138595118 @default.
• W4323308811 cites W2140034264 @default.
• W4323308811 cites W2361623515 @default.
• W4323308811 cites W2565383127 @default.
• W4323308811 cites W2609728913 @default.
• W4323308811 cites W2889297547 @default.
• W4323308811 cites W2900788041 @default.
• W4323308811 cites W2982650396 @default.
• W4323308811 cites W3012379316 @default.
• W4323308811 cites W3016247086 @default.
• W4323308811 cites W3020239101 @default.
• W4323308811 cites W3034907915 @default.
• W4323308811 cites W3089536260 @default.
• W4323308811 cites W3108961313 @default.
• W4323308811 cites W4232586076 @default.
• W4323308811 doi "https://doi.org/10.1016/j.jsps.2023.02.012" @default.
• W4323308811 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/37009425" @default.
• W4323308811 hasPublicationYear "2023" @default.
• W4323308811 type Work @default.
• W4323308811 citedByCount "0" @default.
• W4323308811 crossrefType "journal-article" @default.
• W4323308811 hasAuthorship W4323308811A5007560495 @default.
• W4323308811 hasAuthorship W4323308811A5041368940 @default.
• W4323308811 hasAuthorship W4323308811A5075901927 @default.
• W4323308811 hasAuthorship W4323308811A5084802647 @default.
• W4323308811 hasBestOaLocation W43233088111 @default.
• W4323308811 hasConcept C126322002 @default.
• W4323308811 hasConcept C203014093 @default.
• W4323308811 hasConcept C2777761686 @default.
• W4323308811 hasConcept C2777910003 @default.
• W4323308811 hasConcept C2778130027 @default.
• W4323308811 hasConcept C59822182 @default.
• W4323308811 hasConcept C71924100 @default.
• W4323308811 hasConcept C86803240 @default.
• W4323308811 hasConcept C90924648 @default.
• W4323308811 hasConceptScore W4323308811C126322002 @default.
• W4323308811 hasConceptScore W4323308811C203014093 @default.
• W4323308811 hasConceptScore W4323308811C2777761686 @default.
• W4323308811 hasConceptScore W4323308811C2777910003 @default.
• W4323308811 hasConceptScore W4323308811C2778130027 @default.
• W4323308811 hasConceptScore W4323308811C59822182 @default.
• W4323308811 hasConceptScore W4323308811C71924100 @default.
• W4323308811 hasConceptScore W4323308811C86803240 @default.
• W4323308811 hasConceptScore W4323308811C90924648 @default.
• W4323308811 hasIssue "4" @default.
• W4323308811 hasLocation W43233088111 @default.
• W4323308811 hasLocation W43233088112 @default.
• W4323308811 hasLocation W43233088113 @default.
• W4323308811 hasOpenAccess W4323308811 @default.
• W4323308811 hasPrimaryLocation W43233088111 @default.
• W4323308811 hasRelatedWork W129423339 @default.
• W4323308811 hasRelatedWork W1987215768 @default.
• W4323308811 hasRelatedWork W1991129960 @default.
• W4323308811 hasRelatedWork W1995188757 @default.
• W4323308811 hasRelatedWork W2007817983 @default.
• W4323308811 hasRelatedWork W2016679923 @default.
• W4323308811 hasRelatedWork W2116001782 @default.
• W4323308811 hasRelatedWork W2943195325 @default.
• W4323308811 hasRelatedWork W4229900919 @default.
• W4323308811 hasRelatedWork W17604275 @default.
• W4323308811 hasVolume "31" @default.
• W4323308811 isParatext "false" @default.
• W4323308811 isRetracted "false" @default.
• W4323308811 workType "article" @default.